The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer

被引:15
作者
Pinzone, Marilia Rita [1 ]
Berretta, Massimiliano [2 ]
Doerr, Hans Wilhelm [3 ]
Nunnari, Giuseppe [1 ]
Cacopardo, Bruno [1 ]
机构
[1] Univ Catania, Dept Clin & Mol Biomed, Div Infect Dis, I-95125 Catania, Italy
[2] Natl Canc Inst, Dept Med Oncol, Aviano, PN, Italy
[3] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany
关键词
Aging; Cancer; Chemotherapy; Elderly; Infection; Older people; CHRONIC LYMPHOCYTIC-LEUKEMIA; CLINICAL-PRACTICE GUIDELINE; COLONY-STIMULATING FACTOR; NEUTROPENIC PATIENTS; T-CELLS; ANTIMICROBIAL AGENTS; GROWTH-FACTORS; PHASE-III; IN-VIVO; CHEMOTHERAPY;
D O I
10.2174/18715206113136660346
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aging is associated with a reduced capability of the immune system to adequately respond to pathogens and to prevent tumor formation. As a consequence of immunosenescence, older people have a higher risk to develop infections as well as cancer. In addition, cancer itself may expose old patients to infections, including opportunistic infections, i.e. Pseudomonas aeruginosa, Aspergillus fumigatus and Cytomegalovirus infection. Patients with hematologic malignancies have a higher risk than patients with solid tumors, because of more prolonged disease-related and treatment-related neutropenia and intensive immunosuppressive regimens. Co-existing medical conditions, e.g. chronic renal failure, diabetes mellitus, emphysema, which are quite common in the elderly, may also contribute to rising the infectious risk, as well as the use of long-term vascular catheters, which is required in a large number of cancer patients to administrate chemotherapy. Neutropenic infections do not only represent a major cause of morbidity and mortality, but may be responsible for a reduction of the antineoplastic treatment dose and dose intensity, thus compromising the overall treatment effectiveness. The use of antibiotic prophylaxis to reduce neutropenia-related infectious complications in patients with cancer is still object to debate. Quinolones represent the most attractive option, since these drugs have a broad antimicrobial spectrum, systemic bactericidal activity, good tolerability and lack of myelosuppression. However, fluoroquinolone prophylaxis has already been associated with the emergence and spread of resistant bacteria and strictly precludes the subsequent use of fluoroquinolones for initial empirical therapy; in addition, fluoroquinolones should be administered with caution among elderly patients, especially those with more pronounced vascular or degenerative impairment of the central nervous system, cardiac disease or electrolyte disturbances.
引用
收藏
页码:1444 / 1448
页数:5
相关论文
共 49 条
[1]
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[2]
Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224
[3]
Balducci Lodovico, 2005, J Natl Compr Canc Netw, V3, P572
[4]
Berger Nathan A, 2006, Trans Am Clin Climatol Assoc, V117, P147
[5]
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: Effect of augmented gram-positive activity on infectious morbidity [J].
Bow, EJ ;
Mandell, LA ;
Louie, TJ ;
Feld, R ;
Palmer, M ;
Zee, B ;
Pater, J .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) :183-+
[6]
SPECIFIC HUMORAL IMMUNITY IN THE ELDERLY - IN-VIVO AND IN-VITRO RESPONSE TO VACCINATION [J].
BURNS, EA ;
LUM, LG ;
LHOMMEDIEU, G ;
GOODWIN, JS .
JOURNALS OF GERONTOLOGY, 1993, 48 (06) :B231-B236
[7]
Dysregulation between TH1 and TH2 T cell subpopulations in the elderly [J].
Cakman, I ;
Rohwer, J ;
Schutz, RM ;
Kirchner, H ;
Rink, L .
MECHANISMS OF AGEING AND DEVELOPMENT, 1996, 87 (03) :197-209
[8]
Cancer chemotherapy in the older cancer patient [J].
Carreca, Ignazio ;
Balducci, Lodovico .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2009, 27 (06) :633-642
[9]
INFECTIOUS AND IMMUNOSUPPRESSIVE COMPLICATIONS OF PURINE ANALOG THERAPY [J].
CHESON, BD .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2431-2448
[10]
THE NEW FLUORINATED QUINOLONES FOR ANTIMICROBIAL PROPHYLAXIS IN NEUTROPENIC CANCER-PATIENTS [J].
DELFAVERO, A ;
MENICHETTI, F .
EUROPEAN JOURNAL OF CANCER, 1993, 29A :S2-S6